Updated April 2, 2013
The lab testing giant signs a contract for services and biomarker testing with Bristol-Myers Squibb. LabCorp also says it is expanding tests related to inflammatory bowel disease.
February 8, 2013
LabCorp, the lab testing giant, said Friday it is launching a $1 billion share buyback program.
October 12, 2012
Thomas Mac Mahon, chief executive officer at LabCorp for a decade who then became the firm;s chairman, is retiring from the board of directors.
August 21, 2012
The lab testing firm, which earlier this month was the subject of leveraged buyout rumors on Wall Street, is selling bonds in two $500 million packages.
Updated August 2, 2012
The lab testing firm, which is based in Burlington, says it is "aware" of possible buyout talk but says it's "not in current discussions."
July 19, 2012
June 5, 2012
The Burlington-based company's latest deal - $241 million for Medtox Scientific - is just the latest in a series of acquisitions made over the past three years.
Timeline tracks LabCorp's history, growth
June 4, 2012
Burlington-based Laboratory Corporation of America agrees to buy Medtox Scientific in an all-cash deal worth $241 million.
May 24, 2012
Burlington-based LabCorp will work with XDx to develop a biomarker and commercialize a test for the flares -- extended periods of activity for the autoimmune disease. Lupus causes the body's immune system to attack its own tissues, which leads to inflammation and organ damage.
April 5, 2012
Alzheimer's disease affects more than five million people in the United States and more than 35 million worldwide. There are no specific tests available to detect Alzheimer's disease and track its progression. Diagnosis is currently conducted by behavioral and cognitive measurements.
Updated February 13, 2012
Alien Skin's latest software; SciQuest lands new customer; DadaFlux launches "Learning Café;" LabCorp revenue climbs; Verizon's 4G plans in NC.
December 22, 2011
LabCorp said it has set $1 billion in credit in an arrangement with Bank of America.
December 16, 2011
Laboratory testing and diagnostics firm LabCorp has secured the greater than 90 percent of shares in Orchid that allowed the company to proceed with a short-form merger, meaning the deal could go through without a shareholders meeting.
December 8, 2011
However, as part of the deal LabCorp must sell paternity testing business done for U.S. government to another firm.
November 19, 2011
There is no shortage of companies angling for financial backing of new therapies and diagnostics in personalized medicine. But will challenges of regulations, reimbursements, costs and technical requirements be overcome?
November 17, 2011
SciQuest wins Texas hospital business; ChannelAdvisor adds 26 auto dealers; LabCorp extends Orchid Cellmark offer; Bayer CropScience names new exec; Red Hat Summit seeks papers.
Updated November 15, 2011
Senators ask the company to provide information about discounted or below cost lab services offered to managed care organizations and payers in exchange for referrals of other laboratory testing business to LabCorp.
November 8, 2011
October 11, 2011
LabCorp extends stock offer; Synexcis signs reseller; SciQuest joins two trade groups; Precision BioSciences files patent suit.
August 10, 2011
The lab testing giant's clinical trials services group will work with the Murdock group at the N.C. Research Campus to develop new diagnostics, biomarker assays.